About Athira Pharma
Athira Pharma is a company based in Seattle (United States) founded in 2011.. Athira Pharma has raised $121.04 million across 13 funding rounds from investors including Franklin Templeton, Citadel and HHS. The company has 26 employees as of December 31, 2024. Athira Pharma operates in a competitive market with competitors including Tenaya Therapeutics, Orca Bio, Avita Medical, Tune Therapeutics and Organogenesis, among others.
- Headquarter Seattle, United States
- Employees 26 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Athira Pharma, Inc.
-
Annual Revenue
$00as on Dec 31, 2024
-
Net Profit
$-96.94 M17.62as on Dec 31, 2024
-
EBITDA
$-95.81 M24.04as on Dec 31, 2024
-
Total Equity Funding
$121.04 M (USD)
in 13 rounds
-
Latest Funding Round
$15 M (USD), Grant
Dec 08, 2020
-
Investors
Franklin Templeton
& 21 more
-
Employee Count
26
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Athira Pharma
Athira Pharma is a publicly listed company on the NASDAQ with ticker symbol ATHA in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Unlock access to complete
Unlock access to complete
Funding Insights of Athira Pharma
Athira Pharma has successfully raised a total of $121.04M across 13 strategic funding rounds. The most recent funding activity was a Grant round of $15 million completed in December 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 13
- Last Round Grant — $15.0M
-
First Round
First Round
(25 Jul 2014)
- Investors Count 22
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec, 2020 | Amount | Grant - Athira Pharma | Valuation |
investors |
|
| Sep, 2020 | Amount | Grant - Athira Pharma | Valuation |
investors |
|
| Jun, 2020 | Amount | Series B - Athira Pharma | Valuation | Perceptive Advisors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Athira Pharma
Athira Pharma has secured backing from 22 investors, including institutional, venture fund, and angel investors. Prominent investors backing the company include Franklin Templeton, Citadel and HHS. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Health-tech companies are targeted for venture capital investments.
|
Founded Year | Domain | Location | |
|
Life Sciences focused VC firm investing in the US
|
Founded Year | Domain | Location | |
|
Private investment firm focused on multiple sectors
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Athira Pharma
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Athira Pharma
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Athira Pharma Comparisons
Competitors of Athira Pharma
Athira Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Tenaya Therapeutics, Orca Bio, Avita Medical, Tune Therapeutics and Organogenesis, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Regenerative and gene therapeutics for heart failure are developed.
|
|
| domain | founded_year | HQ Location |
Developer of Allogeneic cell therapy for cancer, autoimmune diseases and genetic blood disorders
|
|
| domain | founded_year | HQ Location |
Products for regenerative and respiratory medicine are developed and distributed.
|
|
| domain | founded_year | HQ Location |
Cell and gene therapies are developed via an epigenomic platform.
|
|
| domain | founded_year | HQ Location |
Regenerative therapies for wound care are developed and commercialized.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Athira Pharma
Frequently Asked Questions about Athira Pharma
When was Athira Pharma founded?
Athira Pharma was founded in 2011 and raised its 1st funding round 3 years after it was founded.
Where is Athira Pharma located?
Athira Pharma is headquartered in Seattle, United States. It is registered at Seattle, Washington, United States.
Who is the current CEO of Athira Pharma?
Mark Litton is the current CEO of Athira Pharma.
Is Athira Pharma a funded company?
Athira Pharma is a funded company, having raised a total of $121.04M across 13 funding rounds to date. The company's 1st funding round was a Series B of $89.01M, raised on Jul 25, 2014.
How many employees does Athira Pharma have?
As of Dec 31, 2024, the latest employee count at Athira Pharma is 26.
What does Athira Pharma do?
Athira Pharma was established in 2011 and is headquartered in Seattle, United States. Operations center on the biotechnology sector, with emphasis placed on developing treatments for neurodegenerative conditions. The primary candidate, Fosgonimeton, targets Alzheimers disease, Parkinsons disease, and multiple dementias. Further assets in the pipeline include ATH-1020, directed at neuropsychiatric disorders, and ATH-1019, aimed at peripheral applications.
Who are the top competitors of Athira Pharma?
Athira Pharma's top competitors include Tenaya Therapeutics, Orca Bio and Avita Medical.
Is Athira Pharma publicly traded?
Yes, Athira Pharma is publicly traded on NASDAQ under the ticker symbol ATHA.
Who are Athira Pharma's investors?
Athira Pharma has 22 investors. Key investors include Franklin Templeton, Citadel, HHS, Alzheimer’s Association, and RTW Investments.
What is Athira Pharma's ticker symbol?
The ticker symbol of Athira Pharma is ATHA on NASDAQ.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.